Clinical Trials Browser

INDUSTRY × Has results × Anemia, Sickle Cell × Clear all

NCT03733249 2023-09-26

Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

Phase 1/2 Terminated

187 enrolled 8 charts

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Primary Immunodeficiency Diseases, Cytopenia, Anemia, Anemia, Aplastic, Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Thalassemia, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Anemia, Diamond-Blackfan, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03036813 2023-07-27

GBT_HOPE

Phase 3 Completed

449 enrolled 17 charts 1 FDA

Classical hematology

Anemia, Sickle Cell

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Phase 3 Completed

230 enrolled 19 charts 1 FDA

Classical hematology

Vaso-Occlusive Crises, Anemia, Sickle Cell

NCT02516579 2020-03-19

ESCORT-HU

1,906 enrolled 9 charts 1 FDA

Classical hematology

Anemia, Sickle Cell

NCT01895361 2020-01-31

SUSTAIN

Phase 2 Completed

198 enrolled 18 charts 1 FDA

Classical hematology

Anemia, Sickle Cell, Priapism